Robert Stockton Jones Jr.

Array ( [id] => 7380318 [patent_doc_number] => 20040081678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Therapeutic process for the treatment of obesity and associated metabolic disorders' [patent_app_type] => new [patent_app_number] => 10/635841 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4595 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081678.pdf [firstpage_image] =>[orig_patent_app_number] => 10635841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674683 [patent_doc_number] => 20040127435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Uses for inhibitors of inosine monophosphate dehydrogenase' [patent_app_type] => new [patent_app_number] => 10/632711 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20129 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127435.pdf [firstpage_image] =>[orig_patent_app_number] => 10632711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748501 [patent_doc_number] => 20060111433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Use of angelicin and of its structural analogues for the treatment of thalassemia' [patent_app_type] => utility [patent_app_number] => 10/522737 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2132 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111433.pdf [firstpage_image] =>[orig_patent_app_number] => 10522737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7396058 [patent_doc_number] => 20040022827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Remedy for hepatopathy' [patent_app_type] => new [patent_app_number] => 10/629838 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4175 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022827.pdf [firstpage_image] =>[orig_patent_app_number] => 10629838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674675 [patent_doc_number] => 20040127443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure' [patent_app_type] => new [patent_app_number] => 10/627372 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21958 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127443.pdf [firstpage_image] =>[orig_patent_app_number] => 10627372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411134 [patent_doc_number] => 07282220 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-16 [patent_title] => 'Genipin-crosslinked gelatin microspheres as drug carrier' [patent_app_type] => utility [patent_app_number] => 10/622303 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 17043 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282220.pdf [firstpage_image] =>[orig_patent_app_number] => 10622303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7412175 [patent_doc_number] => 20040106668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin' [patent_app_type] => new [patent_app_number] => 10/617222 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10583 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106668.pdf [firstpage_image] =>[orig_patent_app_number] => 10617222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952838 [patent_doc_number] => 20050227933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Treatment of bacterial induced diseases using DNA methyl transferase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/615703 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32976 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227933.pdf [firstpage_image] =>[orig_patent_app_number] => 10615703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411300 [patent_doc_number] => 20040106587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium' [patent_app_type] => new [patent_app_number] => 10/614563 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39634 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106587.pdf [firstpage_image] =>[orig_patent_app_number] => 10614563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7452889 [patent_doc_number] => 20040067891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Therapeutic and/or preventive agents for diseases due to retinal ischemia' [patent_app_type] => new [patent_app_number] => 10/451780 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2637 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067891.pdf [firstpage_image] =>[orig_patent_app_number] => 10451780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 846953 [patent_doc_number] => 07384652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Complexed-acidic-phospholipid-collagen composites for bone induction' [patent_app_type] => utility [patent_app_number] => 10/603478 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 6648 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384652.pdf [firstpage_image] =>[orig_patent_app_number] => 10603478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270475 [patent_doc_number] => 20040058993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Inhibitor for the production of TNF alpha' [patent_app_type] => new [patent_app_number] => 10/601699 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2733 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058993.pdf [firstpage_image] =>[orig_patent_app_number] => 10601699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 428715 [patent_doc_number] => 07268149 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders' [patent_app_type] => utility [patent_app_number] => 10/601968 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19945 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268149.pdf [firstpage_image] =>[orig_patent_app_number] => 10601968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876398 [patent_doc_number] => 07358236 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-15 [patent_title] => 'Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents' [patent_app_type] => utility [patent_app_number] => 10/602325 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 6657 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358236.pdf [firstpage_image] =>[orig_patent_app_number] => 10602325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189149 [patent_doc_number] => 06734194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-11 [patent_title] => 'Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation' [patent_app_type] => B2 [patent_app_number] => 10/464570 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16580 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 833 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734194.pdf [firstpage_image] =>[orig_patent_app_number] => 10464570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7239423 [patent_doc_number] => 20040157882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation' [patent_app_type] => new [patent_app_number] => 10/464702 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16620 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157882.pdf [firstpage_image] =>[orig_patent_app_number] => 10464702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330088 [patent_doc_number] => 20040254202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Method of promoting sleep using topical administration of vasoactive agents' [patent_app_type] => new [patent_app_number] => 10/461701 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3023 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254202.pdf [firstpage_image] =>[orig_patent_app_number] => 10461701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664648 [patent_doc_number] => 20030203974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Methods for treating subjects infected with herpes virus or Neisseria gonorrheae' [patent_app_type] => new [patent_app_number] => 10/459101 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8681 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203974.pdf [firstpage_image] =>[orig_patent_app_number] => 10459101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7601761 [patent_doc_number] => 07384940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Method of treating cancer using kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/454323 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5776 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384940.pdf [firstpage_image] =>[orig_patent_app_number] => 10454323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403496 [patent_doc_number] => 20040023893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field' [patent_app_type] => new [patent_app_number] => 10/343241 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5492 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023893.pdf [firstpage_image] =>[orig_patent_app_number] => 10343241 [rel_patent_id] =>[rel_patent_doc_number] =>)